Variant report
Variant | nsv1050201 |
---|---|
Chromosome Location | chr12:60269149-60297702 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555452187 | chr12:60269216-60269217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536736793 | chr12:60269281-60269282 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556742680 | chr12:60269282-60269283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576688631 | chr12:60269321-60269322 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545618080 | chr12:60269338-60269339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73117584 | chr12:60269357-60269358 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs74502710 | chr12:60269434-60269435 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79193741 | chr12:60269435-60269436 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572674464 | chr12:60269457-60269458 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10161437 | chr12:60269471-60269472 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs560055910 | chr12:60269553-60269554 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192714942 | chr12:60269582-60269583 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182747933 | chr12:60269719-60269720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34062063 | chr12:60269737-60269738 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs187821375 | chr12:60269797-60269798 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542724586 | chr12:60269821-60269822 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192769892 | chr12:60269884-60269885 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs571373712 | chr12:60269890-60269891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs141451674 | chr12:60269965-60269966 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563013503 | chr12:60270006-60270007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547382306 | chr12:60270076-60270077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs567662386 | chr12:60270109-60270110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183896892 | chr12:60270114-60270115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs4334056 | chr12:60270118-60270119 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs150833806 | chr12:60270171-60270172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542645954 | chr12:60270183-60270184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551778545 | chr12:60270191-60270192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189019972 | chr12:60270197-60270198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572564482 | chr12:60270216-60270217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541702597 | chr12:60270245-60270246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554888987 | chr12:60270306-60270307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs373366815 | chr12:60270332-60270333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572096804 | chr12:60270368-60270369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12320040 | chr12:60270407-60270408 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs373357290 | chr12:60270412-60270413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs117901326 | chr12:60270444-60270445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528034748 | chr12:60270493-60270494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7960213 | chr12:60270532-60270533 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs531407282 | chr12:60270535-60270536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191941963 | chr12:60270540-60270541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs565888987 | chr12:60270585-60270586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs116674699 | chr12:60270675-60270676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs118159982 | chr12:60270676-60270677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs367564906 | chr12:60270721-60270722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs567601687 | chr12:60270817-60270818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530032949 | chr12:60270851-60270852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373490816 | chr12:60270869-60270870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs570071921 | chr12:60270872-60270873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184739931 | chr12:60270900-60270901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539085334 | chr12:60270928-60270929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 20080666 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Glioblastoma | 17090523 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:60242200-60295600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr12:60266800-60270000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr12:60267800-60269800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr12:60268000-60269600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr12:60268400-60269400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr12:60268600-60269200 | Flanking Active TSS | HUES64 Cell Line | embryonic stem cell |
7 | chr12:60268800-60269200 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
8 | chr12:60268800-60269800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr12:60269000-60269600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr12:60269200-60269600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr12:60269200-60269600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr12:60284800-60285200 | Enhancers | HUVEC | blood vessel |
13 | chr12:60286400-60286800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr12:60288600-60289400 | Enhancers | Fetal Brain Female | brain |
15 | chr12:60288800-60289400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
16 | chr12:60289000-60289800 | Enhancers | Fetal Brain Male | brain |
17 | chr12:60291800-60292200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
18 | chr12:60295600-60296800 | Strong transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
19 | chr12:60296800-60320400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
20 | chr12:60297600-60298400 | Enhancers | NHDF-Ad | bronchial |